Patents Assigned to SUDA LIMITED
  • Publication number: 20150051216
    Abstract: The present disclosure is directed to chemically-stable and pharmaceutically acceptable sildenafil oral spray formulations for the treatment of diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction, wherein the oral spray formulation has a pH of about 1.5 to less than 3.0. The present disclosure is also directed to methods for treating diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction.
    Type: Application
    Filed: December 4, 2012
    Publication date: February 19, 2015
    Applicant: SUDA LIMITED
    Inventors: David Bergstrom, Foye Opawale